[Company Introduction]

PROTIA Inc. aims to contribute to human health and well-being through finding new protein targets for disease prediction, early diagnosis, and development of new medicines.
Based on our dedication for identification of bio-markers needed in early diagnosis of incurable diseases with and our advanced technology in "protein analysis" we have successfully developed unique in vitro diagnosis merchandise such as allergy diagnosis kits, immunity monitoring kits and next-generation pregnancy diagnosis kits, COVID-19 diagnostic kits and are currently developing early cancer diagnosis kits.
As a manufacturer of award-winning in vitro diagnostic medical devices (Jang Yeongsil Award, New Excellent Technology (NET), World-Class Products and more), PROTIA Inc. is a group of talented individuals striving for production of the World's Best Products with strong passion and skills.

[Product Descrpition]

Identify the cause of YOUR ALLERGY!! Detect over 100 allergens in one panel 

PROTIATM Allergy-Q is an in vitro diagnostic test in the quantitative determination of allergen-specific IgE concentrations in human serum or plasma using immunoblotting technique.

Advantage
* Multiple screening over 118 Allergy In 1 Panel
* Small serum volume for testing: 64 Line: 50 µL, 96 Line: 100 µL, 128 line: 150µL
* Multiplex, Quantitative detection of allergen specific IgE
* On strip Internal Calibration lines
* Increased efficiency and affordability
* Valuable and informative report format
* Applicable to Automatic & Semi-Automatic Instrument